Circulating tumor DNA identified by fragment sizeNovember 7, 2018Gynecologic CancerGenitourinary CancerBreast CancerRenal Cell CarcinomaCNS/Brain CancerMelanoma
First combo trial of mTOR/BRAF inhibition shows potentialSeptember 23, 2018MelanomaLung CancerCNS/Brain CancerGastroenterologyHead & Neck/Thyroid CancersGastrointestinal Cancer
Nivolumab plus ipilimumab effective in melanoma brain metastasesAugust 27, 2018MelanomaCNS/Brain CancerImmuno-oncology
Adding checkpoint inhibitors to radiotherapy requires particular caution in this one scenarioAugust 24, 2018Immuno-oncologyLung CancerCNS/Brain CancerMelanoma
Immunotherapies extend survival for melanoma patients with brain metastasesJuly 12, 2018Immuno-oncologyNeuro-oncologyCNS/Brain CancerMelanoma
Recombinant poliovirus appears safe, active as recurrent glioblastoma treatmentJuly 10, 2018CNS/Brain CancerNeuro-oncology
Screening for brain mets could improve quality of life for some with breast cancerMay 24, 2018Breast CancerCNS/Brain CancerLung Cancer
cfDNA reveals targetable mutations in pediatric neuroblastoma, sarcomaMay 20, 2018Sarcoma & GISTCNS/Brain Cancer
Study: Test for PD-L1 amplification in solid tumorsFebruary 7, 2018Nonmelanoma Skin CancerImmuno-oncologyCNS/Brain Cancer
FDA: Gadolinium retention prompts new GBCA class warning, safety measuresDecember 20, 2017Patient & Survivor CareNeuro-oncologyCNS/Brain Cancer
FDA approves biosimilar to bevacizumabSeptember 14, 2017GastroenterologyLung CancerGynecologic CancerCNS/Brain CancerRenal Cell CarcinomaNeuro-oncologyGastrointestinal Cancer
Glioblastoma: Prognosis is poor, but new therapies are emergingJuly 28, 2017CNS/Brain CancerNeuro-oncology
VIDEO: Immune therapy effective, durable in treatment-naive melanoma brain metastasesJune 12, 2017MelanomaImmuno-oncologyImmunotherapyCNS/Brain Cancer
